# An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab

> **NCT04249713** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Rockefeller University**

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Brodalumab

## Key facts

- **NCT ID:** NCT04249713
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-02-03
- **Primary completion:** 2020-07
- **Final completion:** 2020-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Biomarker Samples Not Collected
- **Last updated:** 2020-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04249713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04249713, "An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04249713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*